MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinoma
- PMID: 23162473
- PMCID: PMC3496902
- DOI: 10.3389/fphys.2012.00430
MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinoma
Abstract
MSX2, a member of the homeobox genes family, is demonstrated to be the downstream target for ras signaling pathway and is expressed in a variety of carcinoma cells, suggesting its relevance to the development of ductal pancreatic tumors since pancreatic ductal adenocarcinoma (PDAC) and intraductal papillary-mucinous neoplasia (IPMN) harbor frequent K-ras gene mutations. Recent studies revealed the roles of MSX2 in the development of carcinoma of various origins including pancreas. Among gastrointestinal tumors, PDAC is one of the most malignant. PDAC progresses rapidly to develop metastatic lesions, frequently by the time of diagnosis, and these tumors are usually resistant to conventional chemotherapy and radiation therapy. The molecular mechanisms regulating the aggressive behavior of PDAC still remain to be clarified. On the other hand, IPMN of the pancreas is distinct from PDAC because of its intraductal growth in the main pancreatic duct or secondary branches with rare invasion and metastasis to distant organs. However, recent evidence indicated that once IPMN showed stromal invasion, it progresses like PDAC. Therefore, it is important to determin how IPMN progresses to malignant phenotype. In this review, we focus on the involvement of MSX2 in the enhancement of malignant behavior in PDAC and IPMN, and further highlight the clinical approach to differentiate PDAC from chronic pancreatitis by evaluating MSX2 expression level.
Keywords: MSX2; cancer development; homeobox gene; intraductal papillary-mucinous neoplasm of the pancreas; pancreatic ductal adenocarcinoma.
Figures
Similar articles
-
Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas.J Gastroenterol. 2010 Jul;45(7):763-70. doi: 10.1007/s00535-010-0200-1. Epub 2010 Jan 28. J Gastroenterol. 2010. PMID: 20107842
-
Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm".Virchows Arch. 2020 Dec;477(6):799-806. doi: 10.1007/s00428-020-02844-2. Epub 2020 May 28. Virchows Arch. 2020. PMID: 32468246
-
Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.Pancreas. 2013 Nov;42(8):1267-74. doi: 10.1097/mpa.0b013e3182954137. Pancreas. 2013. PMID: 24308063
-
Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.J Hepatobiliary Pancreat Sci. 2015 Jul;22(7):519-23. doi: 10.1002/jhbp.246. Epub 2015 Apr 21. J Hepatobiliary Pancreat Sci. 2015. PMID: 25900667 Review.
-
Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms.World J Clin Oncol. 2019 Feb 24;10(2):67-74. doi: 10.5306/wjco.v10.i2.67. World J Clin Oncol. 2019. PMID: 30815373 Free PMC article. Review.
Cited by
-
Prognostic Relevance and Function of MSX2 in Colorectal Cancer.J Diabetes Res. 2017;2017:3827037. doi: 10.1155/2017/3827037. Epub 2017 Feb 12. J Diabetes Res. 2017. PMID: 28286778 Free PMC article.
-
MSX2 safeguards syncytiotrophoblast fate of human trophoblast stem cells.Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):e2105130118. doi: 10.1073/pnas.2105130118. Proc Natl Acad Sci U S A. 2021. PMID: 34507999 Free PMC article.
-
MSX2 Induces Trophoblast Invasion in Human Placenta.PLoS One. 2016 Apr 18;11(4):e0153656. doi: 10.1371/journal.pone.0153656. eCollection 2016. PLoS One. 2016. PMID: 27088357 Free PMC article.
-
The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review.BMC Cancer. 2023 Dec 18;23(1):1245. doi: 10.1186/s12885-023-11723-3. BMC Cancer. 2023. PMID: 38110859 Free PMC article.
-
A six-gene-based prognostic model predicts complete remission and overall survival in childhood acute myeloid leukemia.Onco Targets Ther. 2019 Aug 16;12:6591-6604. doi: 10.2147/OTT.S218928. eCollection 2019. Onco Targets Ther. 2019. PMID: 31496748 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous